Tag: bimekizumab

All

Study results presented at EADV 2025 show nearly half of initial complete responders maintained clearance over four years.

The Clear + Brilliant Touch laser, cleared by the FDA in 2022, includes two wavelengths designed to address wrinkles, pigmentation, and skin texture.